Selecting an appropriate all-oral short-course regimen for patients with multidrug-resistant or pre-extensive drug-resistant tuberculosis in China: A multicenter prospective cohort study
Author:
Publisher
Elsevier BV
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference21 articles.
1. World Health Organization. Global tuberculosis report 2021. Geneva: World Health Organization, 2021.
2. Tuberculosis, drug resistance, and the history of modern medicine;Keshavjee;N Engl J Med,2012
3. Meeting report of the WHO expert consultation on the definition of extensively drug-resistant tuberculosis,2021
4. Global tuberculosis Report 2020 - Reflections on the Global TB burden, treatment and prevention efforts;Chakaya;Int J Infect Dis,2021
5. Epidemiology of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: a systematic review and meta-analysis;Diriba;Int J Infect Dis,2023
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Faster, higher, stronger: the evolution of clinical perspectives on pan-TB;One Health & Implementation Research;2024-06-27
2. Study protocol for safety and efficacy of all-oral shortened regimens for multidrug-resistant tuberculosis: a multicenter randomized withdrawal trial and a single-arm trial [SEAL-MDR];BMC Infectious Diseases;2023-11-27
3. Community-acquired pneumonia: antibiotic therapy approach after the COVID-19 pandemic. A review;Consilium Medicum;2023-10-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3